Recon: FDA may rethink shortage listing for Eli Lilly’s tirzepatide; Pfizer nabs FDA approval for injectable Hympavzi for hemophilia
ReconJason Scott
Biologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsReconJason ScottBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticals